NRC Health names CEO interim CFO after finance chief resigns
Key Facts
NRC Health’s board appointed Chief Executive Trent Green interim chief financial officer on October 14, 2026, according to a company filing with the U.S. Securities and Exchange Commission. The decision places Green in an interim finance role alongside his leadership of the company, following the vacancy in the CFO position. Green signed the filing as chief executive on October 19. The company said his appointment did not come with any change in his compensation. It also said there were no arrangements or understandings between Green and any other person regarding the appointment, and that he had no material interest in any transaction requiring disclosure under Item 404(a).
The appointment follows the resignation of CFO Shane Harrison, who submitted his resignation on August 7, 2026, to pursue a professional opportunity outside the company, with his departure effective August 28. NRC Health said in its resignation filing that it had begun a search for a new CFO. Green’s interim appointment indicates that he will assume financial responsibility during this period, while the search for a permanent successor remains the course the company announced after Harrison’s resignation. The appointment filing did not specify when a new CFO would be selected. It also did not cite any change to Green’s compensation terms related to the interim assignment.
Green has served as chief executive since June 2025, according to the company filing. Before joining NRC Health, he was chief executive of Amazon One Medical from September 2023 through February 2025. He also served as its chief operating officer from July 2022 through August 2023. That experience provides context for his executive career before taking the helm at NRC Health. His current assignment adds interim financial oversight responsibilities, according to the filing. The company did not disclose further details in the available material about how his executive duties would be allocated during the assignment.
The latest documented financial results in the available information are for the second quarter of 2026, when revenue was $35.4 million, up 4% from the second quarter of 2025. The company recorded a GAAP net loss of $3.3 million, or $0.15 a diluted share, for the same period. Net loss in the second quarter of 2025 was $106 thousand, compared with $3.283 million in the corresponding period of 2026, according to figures in the company’s results filing with the Securities and Exchange Commission. Annual revenue growth therefore coincided with a wider net loss compared with the year-earlier period. These figures reflect second-quarter performance and do not establish third-quarter financial results.
In a separate operating indicator, total recurring contract value rose 11% year over year to $151.9 million in the second quarter. The chief executive said bookings at The Governance Institute posted their strongest performance in seven years. He added that this performance positioned the company well for the second half of 2026, according to the second-quarter results statement. Those remarks combine growth in contract value with strong bookings at the institute, while the second-quarter result under the accounting measure remained a net loss. Recurring contract value is not revenue recorded during the quarter, which was $35.4 million.
The board declared a quarterly cash dividend of $0.16 a share on July 15, 2026. The statement set September 25 as the record date for eligible shareholders and October 9 as the payment date. The announcement relates to the second-quarter results and does not establish a new dividend tied to the third quarter. As for the next results, the available information does not include a date for the release of third-quarter results. It also does not confirm figures in circulation for third-quarter revenue, net income, earnings per share or recurring contract value; the latest documented results here therefore remain those for the second quarter, alongside the October interim appointment filing.